Explore All Access
Check if your research matches the topics covered in Oncology and Therapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Oncology and Therapy : Impact Factor & More
eISSN: 2366-1089pISSN: 2366-1070
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Oncology and Therapy Key Metrics
CiteScore 
0.3
H-Index
5
SJR
Q2Oncology
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months57%
4 to 6 months36%
7 to 9 months4%
Above 9 months4%
Did you find this useful?
Topics Covered on Oncology and Therapy
Cancer
Chloride channel
Superficial radiotherapy
Bevacizumab
Lenalidomide
Skin cancer
Tyrosine kinase
Objective response
Refractory Multiple Myeloma
Overall survival
Diarrhea
Complete resection
Advanced disease
Penile cancer
Liquid biopsy
Quality of life
Maintenance therapy
Epidermal growth factor receptor
Reference product
Pandemic
Oncology and Therapy Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Semi-annual |
| Article Processing Charges | EUR 4500 | USD 5600 | GBP 4100 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Semi-annual |
| Publication Start Year | 2016 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Oncology and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Oncology and Therapy
Study on the Impact of Hormone Therapy for Prostate Cancer on the Quality of Life and the Psycho-Relational Sphere of Patients: ProQoL.
- 13 Nov 2024
- Oncology and therapy
Cost-Effectiveness of Pembrolizumab as First-Line Treatment in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer in the United States.
- 5 Nov 2024
- Oncology and therapy
A Narrative Review of the Clinical, Humanistic, and Economic Value of Pembrolizumab-Based Immunotherapy for the Treatment of Breast and Gynecologic Cancers.
- 25 Oct 2024
- Oncology and therapy
Stereotactic Radiotherapy Plus Nivolumab in Patients with Locally Advanced Pancreatic Cancer: Results from Phase 1/2 Clinical CA209-9KH Trial.
- 23 Oct 2024
- Oncology and therapy
Understanding Treatment Decisions and Management for Patients with Advanced Renal Cell Carcinoma Using Hypothetical Case Studies: A Vodcast.
- 2 Oct 2024
- Oncology and therapy
A Patient-Relevant Measurement Strategy to Assess Clinical Benefit of Novel Therapies for Non-metastatic Cutaneous Squamous Cell Carcinoma.
- 1 Oct 2024
- Oncology and therapy
Study on the Impact of Hormone Therapy for Prostate Cancer on the Quality of Life and the Psycho-Relational Sphere of Patients: ProQoL.
- 13 Nov 2024
- Oncology and therapy
Cost-Effectiveness of Pembrolizumab as First-Line Treatment in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer in the United States.
- 5 Nov 2024
- Oncology and therapy
A Narrative Review of the Clinical, Humanistic, and Economic Value of Pembrolizumab-Based Immunotherapy for the Treatment of Breast and Gynecologic Cancers.
- 25 Oct 2024
- Oncology and therapy
Stereotactic Radiotherapy Plus Nivolumab in Patients with Locally Advanced Pancreatic Cancer: Results from Phase 1/2 Clinical CA209-9KH Trial.
- 23 Oct 2024
- Oncology and therapy
Understanding Treatment Decisions and Management for Patients with Advanced Renal Cell Carcinoma Using Hypothetical Case Studies: A Vodcast.
- 2 Oct 2024
- Oncology and therapy
A Patient-Relevant Measurement Strategy to Assess Clinical Benefit of Novel Therapies for Non-metastatic Cutaneous Squamous Cell Carcinoma.
- 1 Oct 2024
- Oncology and therapy
Compare Similar Journals with Oncology and Therapy
Select Journals to Compare with Oncology and Therapy
Total journals - 9
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Annals of Oncology
Publisher: ELSEVIER
Cancers
Publisher: MDPI
Medicine
Publisher: Elsevier
BMC Cancer
Publisher: BMC
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Translational Cancer Research
Publisher: AME PUBLISHING COMPANY
European Journal of Cancer
Publisher: ELSEVIER SCI LTD
0 Journals Selected to compare with
Oncology and Therapy
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Oncology and Therapy
How long has Oncology and Therapy been actively publishing? 
Oncology and Therapy has been in operation since 2016 till date.
What is the publishing frequency of Oncology and Therapy?
Oncology and Therapy published with a Semi-annual frequency.
How many articles did Oncology and Therapy publish last year?
In 2023, Oncology and Therapy publsihed 38 articles.
What is the eISSN & pISSN for Oncology and Therapy?
For Oncology and Therapy, eISSN is 2366-1089 and pISSN is 2366-1070.
What is Citescore for Oncology and Therapy?
Citescore for Oncology and Therapy is 0.3.
What is the H Index for Oncology and Therapy ?
H Index for Oncology and Therapy is 5.
What is the SJR for Oncology and Therapy?
SJR for Oncology and Therapy is Q2.
Who is the publisher of Oncology and Therapy?
SPRINGER is the publisher of Oncology and Therapy.
